Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
HIMS
Upturn stock ratingUpturn stock rating

Hims Hers Health Inc (HIMS)

Upturn stock ratingUpturn stock rating
$47.13
Last Close (24-hour delay)
Today's Top Performer Top performer
Profit since last BUY-21.8%
upturn advisory
WEAK BUY
BUY since 13 days
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

08/14/2025: HIMS (5-star) is a WEAK-BUY. BUY since 13 days. Profits (-21.80%). Updated daily EoD!

Upturn Star Rating

rating

Outstanding Performance

These Stocks/ETFs, based on Upturn Advisory, have historically outperformed the market, making them a top-tier choice for investors.

Number of Analysts

rating

13 Analysts rated it

Moderately tracked stock, growing coverage, gaining market and investor attention.

1 Year Target Price $50.45

1 Year Target Price $50.45

Analysts Price Target For last 52 week
$50.45 Target price
52w Low $13.47
Current$47.13
52w High $72.98

Analysis of Past Performance

Type Stock
Historic Profit 154.2%
Avg. Invested days 31
Today’s Advisory WEAK BUY
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 4.0
Stock Returns Performance Upturn Returns Performance 5.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 08/14/2025

Key Highlights

Company Size Large-Cap Stock
Market Capitalization 10.65B USD
Price to earnings Ratio 59.66
1Y Target Price 50.45
Price to earnings Ratio 59.66
1Y Target Price 50.45
Volume (30-day avg) 13
Beta 2.09
52 Weeks Range 13.47 - 72.98
Updated Date 08/15/2025
52 Weeks Range 13.47 - 72.98
Updated Date 08/15/2025
Dividends yield (FY) -
Basic EPS (TTM) 0.79

Earnings Date

Report Date 2025-08-04
When -
Estimate 0.15
Actual 0.17

Profitability

Profit Margin 9.61%
Operating Margin (TTM) 4.91%

Management Effectiveness

Return on Assets (TTM) 6.94%
Return on Equity (TTM) 41.88%

Valuation

Trailing PE 59.66
Forward PE 89.29
Enterprise Value 10552075851
Price to Sales(TTM) 5.29
Enterprise Value 10552075851
Price to Sales(TTM) 5.29
Enterprise Value to Revenue 5.24
Enterprise Value to EBITDA 68.18
Shares Outstanding 217642000
Shares Floating 197509471
Shares Outstanding 217642000
Shares Floating 197509471
Percent Insiders 11
Percent Institutions 89.04

ai summary icon Upturn AI SWOT

Hims Hers Health Inc

stock logo

Company Overview

overview logo History and Background

Hims & Hers Health, Inc. was founded in 2017. Initially focused on men's wellness products, it quickly expanded to include women's health services. The company went public via SPAC in January 2021.

business area logo Core Business Areas

  • Telehealth Services: Offers virtual consultations with licensed healthcare providers for a range of conditions, including dermatology, mental health, and sexual health.
  • Personalized Medications: Provides access to prescription medications, often customized to individual patient needs, through its affiliated pharmacies.
  • Over-the-Counter Products: Sells a variety of over-the-counter health and wellness products, including supplements, skincare, and hair care items.

leadership logo Leadership and Structure

Andrew Dudum is the CEO. The company has a traditional corporate structure with departments such as marketing, technology, operations, and finance.

Top Products and Market Share

overview logo Key Offerings

  • Erectile Dysfunction Treatments: Offers sildenafil and tadalafil, generic versions of Viagra and Cialis. Competitors include Roman (GetRoman Inc). Market share data is difficult to obtain due to the fragmented nature of the online pharmacy market, but Hims & Hers are major players in this space. Revenue not publicly broken down by specific product.
  • Hair Loss Treatments: Offers finasteride and minoxidil for hair loss. Competitors include Keeps (Thirty Madison). Similar to ED treatments, specific market share is hard to pinpoint, however hair loss is a key revenue driver for the company. Revenue not publicly broken down by specific product.
  • Mental Health Services: Provides access to therapy and medication for anxiety and depression. Competitors include Talkspace (TALK) and Teladoc (TDOC). Revenue not publicly broken down by specific product.
  • Skincare Products: Offers customized skincare treatments for acne and aging. Competitors include Curology. Revenue not publicly broken down by specific product.

Market Dynamics

industry overview logo Industry Overview

The telehealth market is experiencing rapid growth, driven by increasing access to technology, rising healthcare costs, and a growing demand for convenient healthcare solutions. The market is fragmented with both large established players and newer direct to consumer companies.

Positioning

Hims & Hers is positioned as a direct-to-consumer telehealth provider focused on providing convenient and affordable access to healthcare for common conditions. Their competitive advantages include strong branding, a vertically integrated supply chain, and a focus on personalized treatments.

Total Addressable Market (TAM)

The global telehealth market is estimated to reach hundreds of billions of dollars. Hims & Hers is well-positioned to capture a significant portion of this market, focusing on specific niches like men's and women's health.

Upturn SWOT Analysis

Strengths

  • Strong brand recognition
  • Direct-to-consumer model
  • Vertically integrated supply chain
  • Personalized treatments
  • Growing subscriber base

Weaknesses

  • Reliance on prescription medications
  • Marketing Costs
  • Negative Profit Margins
  • Competition from established healthcare providers

Opportunities

  • Expanding into new therapeutic areas
  • Partnering with healthcare systems
  • Increasing international presence
  • Developing new technologies
  • Acquiring smaller telehealth companies

Threats

  • Increased competition
  • Changes in regulations
  • Economic downturn
  • Data security breaches
  • Adverse drug reactions

Competitors and Market Share

competitor logo Key Competitors

  • Teladoc Health Inc (TDOC)
  • GoodRx Holdings Inc (GDRX)
  • Amazon.com Inc (AMZN)
  • Thirty Madison (Private)

Competitive Landscape

Hims & Hers competes with both established telehealth providers and newer direct-to-consumer companies. Its strengths include its strong brand and vertically integrated supply chain. Its weaknesses include its reliance on prescription medications and its lack of profitability.

Growth Trajectory and Initiatives

Historical Growth: The company has experienced rapid revenue growth since its inception.

Future Projections: Analysts project continued revenue growth, but profitability is expected to remain a challenge.

Recent Initiatives: Recent initiatives include expanding into new therapeutic areas, partnering with healthcare providers, and launching new products.

Summary

Hims & Hers is a rapidly growing telehealth company with a strong brand and a direct-to-consumer model. It has experienced significant revenue growth, but profitability remains a challenge. Key strengths include their brand and vertical integration, while reliance on marketing spending and prescription drugs may limit expansion. The company should focus on reducing expenses and expanding service offerings.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company SEC Filings
  • Analyst Reports
  • Industry Research Reports

Disclaimers:

The data and analysis provided are for informational purposes only and should not be considered financial advice. Market share data is approximate and based on available information. Invest at your own risk.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Hims Hers Health Inc

Exchange NYSE
Headquaters San Francisco, CA, United States
IPO Launch date 2019-09-13
Co-Founder, Chairman & CEO Mr. Andrew Dudum
Sector Consumer Defensive
Industry Household & Personal Products
Full time employees 1637
Full time employees 1637

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.